• Medicines appraisals and guidance
  • Appraisals in progress
  • Medicines appraisals
    • phenazone and lidocaine (Otigo®)
    • ipilimumab (Yervoy®)
  • Medicines optimisation
    • National Prescribing Indicators and reports
      • National Prescribing Indicators 2020-2021
        • National Prescribing Indicators 2020-2021: Quarterly reports
      • National Prescribing Indicators 2019-2020
        • National Prescribing Indicators 2019-2020: Quarterly reports
      • National Prescribing Indicators 2018-2019
        • National Prescribing Indicators 2018-2019: Quarterly reports
      • National Prescribing Indicators 2017-2018
        • National Prescribing Indicators 2017-2018: Quarterly reports
      • National Prescribing Indicators 2016-2017
        • National Prescribing Indicators 2016-2017: Quarterly reports
      • National Prescribing Indicators 2015-2016
        • National Prescribing Indicators 2015-2016: Quarterly reports
      • National Prescribing Indicators 2014-2015
        • National Prescribing Indicators 2014-2015: Quarterly reports
      • National Prescribing Indicators 2013-2014
        • National Prescribing Indicators 2013-2014: Quarterly reports
      • National Prescribing Indicators 2012-2013
        • National Prescribing Indicators 2012-2013: Quarterly reports
    • Prescribing guidance
      • Shared care prescribing and monitoring guidance
      • Prescribing dilemmas: A guide for prescribers
      • Best practice reminder: Avoid nitrofurantoin in the treatment of pyelonephritis
      • Welsh National Standards for Medication Review
      • Persistent pain resources
      • Safeguarding users of opioid patches by standardising patient and caregiver counselling
      • Items identified as low value for prescribing in NHS Wales
      • All Wales Adult Asthma Management and Prescribing Guidelines
      • All Wales Guidance for Health Boards/Trusts and Social Care Providers in Respect of Medicines and Care Support Workers
      • All Wales advice on oral anticoagulation for non-valvular atrial fibrillation
      • Endocrine management of gender dysphoria in adults
      • All Wales COPD management and prescribing guideline
      • Guide to prescribing gluten-free products
      • Primary care antimicrobial guidelines
      • Safe use of proton pump inhibitors
      • Pharmacotherapy for smoking cessation
      • Common ailments formulary
      • Multidisciplinary medicines reconciliation policy
      • Chronic kidney disease
      • Material to support appropriate prescribing of hypnotics and anxiolytics across Wales
      • Dry eye syndrome guidance
      • Vitamins for babies, children, and pregnant and breastfeeding women
      • Prescribing of Low Molecular Weight Heparin in Wales
      • Prescribing of amiodarone for atrial fibrillation and atrial flutter in Wales
      • Guidance for partnership working between NHS organisations, primary care contractors, the pharmaceutical industry and allied commercial sector in Wales
      • Medicines and health care support workers
      • Medicines administration, recording, review, storage and disposal
      • Guidance on antimicrobial prophylaxis related to Caesarean Section
      • Guidance to support the safe use of long-term oral bisphosphonate therapy
      • Handbook for homecare services in Wales
    • National prescribing audits
      • CEPP National Audit - antipsychotics in dementia
      • CEPP National Audit - medicines management for chronic kidney disease
      • CEPP National Audit - towards appropriate non-steroidal anti-inflammatory drug (NSAID) prescribing
      • CEPP National Audit - focus on antibiotic prescribing
    • Patient information leaflets
    • Prescribing analysis
      • Annual Prescribing Reports
        • Annual Prescribing Reports 2018–2019
        • Annual Prescribing Reports 2019–2020
      • Monitoring of medicines appraised by NICE and AWMSG
      • Primary care prescribing analysis - medicines used in diabetes
      • Primary care prescribing analysis for Tramadol
      • Respiratory prescribing analysis with cluster level comparators
      • GP cluster level comparators
      • Primary care prescribing analysis 2012-2013 gluten-free products
    • Medication charts and records
      • In-patient Medication Administration Record
    • Therapeutic priorities and Clinical Effectiveness Prescribing Programme (CEPP)
      • Therapeutic Priorities and CEPP Summary 2020-2021
      • Therapeutic priorities and CEPP summary 2019-2020
      • Therapeutic priorities and CEPP summary 2018-2019
      • Therapeutic priorities and CEPP summary 2017-2018
      • Therapeutic priorities and CEPP summary 2016-2017
      • Therapeutic priorities and CEPP summary 2015-2016
      • Therapeutic priorities and CEPP summary 2014-2015
    • Consultations
      • Medicines Optimisation Framework (Consultation)
  • Accessing medicines in Wales
• Make a submission
  • Make a submission - pharmaceutical industry
    • Submit horizon scanning information
    • Submit for AWMSG appraisal
    • Submit a Wales Patient Access Scheme (WPAS)
    • Pharmaceutical industry opinion for medicines consultations
  • Make a submission - healthcare professionals
  • Make a submission - patients, carers and the public
• Get involved
  • Get involved - patients and public
  • Get involved - healthcare professionals
  • Get involved - pharmaceutical industry
• Meetings and events
  • Meetings
    • AWMSG meetings
      • AWMSG meetings 2021
        • 9 February 2021
        • 10 March 2021
        • 20 April 2021
        • 19 May 2021
        • 15 June 2021
        • 14 July 2021
        • 14 September 2021
        • 13 October 2021
        • 9 November 2021
        • 8 December 2021
      • Previous AWMSG meetings 1
        • 2019 meetings
        • 2017 meetings
        • 2015 meetings
        • 2013 meetings
        • 2011 meetings
        • 2009 meetings
        • 2007 meetings
        • 2005 meetings
        • 2003 meetings
      • Previous AWMSG meetings 2
        • 2020 meetings
        • 2018 meetings
        • 2016 meetings
        • 2014 meetings
        • 2012 meetings
        • 2010 meetings
        • 2008 meetings
        • 2006 meetings
        • 2004 meetings
        • 2002 meetings
    • AWPAG meetings
      • Previous AWPAG meetings 2
        • 2020 meetings
        • 2018 meetings
        • 2016 meetings
        • 2014 meetings
        • 2012 meetings
        • 2010 meetings
        • 2008 meetings
        • 2006 meetings
        • 2004 meetings
      • Previous AWPAG meetings 1
        • 2019 meetings
        • 2017 meetings
        • 2015 meetings
        • 2013 meetings
        • 2011 meetings
        • 2009 meetings
        • 2007 meetings
        • 2005 meetings
        • 2003 meetings
    • NMG meetings
    • PAPIG meetings
• About us
  • Who we are
    • Committees
  • What we do
    • what we do
  • Who we work with
  • Our strategy and annual reports
    • AWMSG 5 Year Strategy 2018-2023
• Contact us
• News
  • Latest News
    • AWMSG hosts first virtual Open Day for Pharmaceutical Industry
    • In review: AWMSG publishes Annual Report 2019-2020
    • New medicines advice for NHS Wales
    • New medicines advice for NHS Wales
    • New medicines advice for NHS Wales
    • AWMSG supports World Patient Safety Day 2020
    • New medicines advice for NHS Wales
    • AWTTC expands educational remit with new collaboration
    • Positive review by AWMSG sees HIV prevention drug made routinely available in Wales
    • Coronavirus (COVID-19) - therapeutic advice
    • New medicines advice for NHS Wales
    • Presentation at 5th Annual Welsh Rare Disease Patient Network Meeting
    • New medicines advice for NHS Wales
    • New medicines advice for NHS Wales
    • New medicines advice for NHS Wales
    • New Chair appointed to All Wales Medicines Strategy Group

• AWTTC
• NHS Wales
• NHS 111 Wales

• Accessibility
• Feedback